ArticleJournal of cancer research and clinical oncology2022

A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study.

Xin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.